Detection of Minimal Residual Disease by Flow Cytometry for Patients with Multiple Myeloma Submitted to Autologous Hematopoietic Stem Cell Transplantation

Table 2

Results of patients at 3 months.

	MRD (3 months)	Status (preTCTH)	Status; (end of study)	Immunoglobulin type
1	−	VGPR	D	IgG
2	−	CR	CR	IgG
3	−	CR	CR	IgG
4	−	VGPR	D	IgG
5	−	CR	CR	Kappa light chain
6	−	PR	D	IgA
7	+	PR	VGPR	IgG
8	−	PR	VGPR	IgA
9	−	CR	CR	Kappa light chain
10	−	VGPR	R	Lambda light chain
11	+	PR	D	IgG
12	−	CR	VGPR	IgG
13	−	CR	CR	IgG
14	−	VGPR	PR	IgG
15	+	PR	D	IgA
16	+	PR	R	IgA
17	−	CR	*	IgG
18	+	VGPR	CR	IgG
19	+	CR	VGPR	IgG
20	+	CR	CR	IgG
21	+	CR	CR	Lambda light chain
22	+	VGPR	VGPR	IgG
23	+	PR	VGPR	IgG
25	−	VGPR	VGPR	Kappa light chain
28	−	PR	D	IgG
30	−	VGPR	CR	IgG
31	−	CR	CR	IgG
32	−	VGPR	VGPR	IgG
33	−	CR	VGPR	IgG
35	+	PR	R	IgA
36	−	PR	VGPR	Kappa light chain
37	−	PR	D	IgA
38	+	VGPR	VGPR	IgG
39	+	VGPR	VGPR	Kappa light chain
40	+	VGPR	VGPR	IgA
41	+	PR	D	IgA
42	+	PR	PR	IgA
43	−	VGPR	VGPR	IgG
44	−	VGPR	VGPR	IgA
45	−	VGPR	VGPR	IgG

(D) Died; (R) relapse; (PR) partial remission; (VGPR) very good PR; (CR) complete remission.
(+) FCM > 0,01% neoplastic PC immunophenotype.
(−) FCM ≤ 0,01% PC neoplastic immunophenotype.